Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38224

KPNA6 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

KPNA6 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T cells. The KPNA6 gene encodes importin alpha 7, an adaptor that mediates nuclear import of cargoes such as NF-??B and p53 by binding classical NLS motifs and partnering with importin beta. Disruption of KPNA6 blocks this critical transport pathway, impacting signal transduction and viral replication. These cells provide a robust model for studying nucleocytoplasmic transport, host-pathogen interactions, and cancer signaling. Applications include nuclear import assays, co-immunoprecipitation, NF-??B luciferase reporters, and transcriptomics. The polyclonal format ensures diverse editing events for reliable loss-of-function experiments.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    KPNA6

    Gene Identifier

    NCBI Gene ID 23633

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

KPNA6 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the widely used HEK293T human embryonic kidney cell line. This model disrupts the KPNA6 gene, which encodes importin alpha 7, a key adaptor in the classical nuclear import pathway. The polyclonal nature ensures representation of diverse editing events, providing a robust loss-of-function system for studying nucleocytoplasmic transport without the clonal artifacts of single-cell isolates.

HEK293T cells are a derivative of HEK293 that stably express the SV40 large T antigen, enabling efficient episomal replication of plasmids containing the SV40 origin and supporting high-level transfection and protein expression. This makes them a preferred host for mechanistic studies requiring transient or stable expression of reporters, viral components, or signaling factors. Their epithelial origin and well-characterized transcriptome further facilitate investigation of nuclear transport processes and transcriptional regulation.

KPNA6 (importin alpha 7) functions as an adaptor that recognizes classical nuclear localization signals (NLS) on cargo proteins and, together with importin beta (KPNB1), mediates translocation through the nuclear pore complex. It is critical for the nuclear import of numerous transcription factors and viral proteins, including NF-??B (p50/p65), p53, STAT1, and BRCA1, as well as influenza virus NP and HIV-1 Vpr. KPNA6 interacts with KPNB1, nucleoporins such as Nup50 and Nup153, and the Ran GTPase cycle components RCC1 and RanGAP1 to orchestrate directional transport. Its activity is modulated by cell cycle regulators, stress signals, and interferon-gamma, linking nuclear import to broad cellular responses. Disruption of KPNA6 consequently impairs downstream signaling pathways such as NF-??B and p53, thereby affecting cell survival, immune responses, and oncogenic transformation.

In HEK293T cells, KPNA6 knockout creates a defined system to dissect importin isoform-specific functions. Because HEK293T cells endogenously express multiple importin alpha family members, loss of KPNA6 allows researchers to assign specific cargoes to KPNA6-dependent import and to evaluate functional redundancy. This model also provides a clean background for reconstitution experiments with mutant forms of KPNA6 or for studying compensatory mechanisms. The combination of the cell line??s high transfectability and efficient viral replication properties with KPNA6 deficiency enables detailed host-pathogen interaction studies, particularly for viruses that hijack the nuclear import machinery. Moreover, the polyclonal population mitigates off-target concerns by averaging out clonal variation.

Typical applications include subcellular localization assays using immunofluorescence or GFP-NLS reporters to quantify nuclear import efficiency, co-immunoprecipitation to map KPNA6-cargo interactions, and luciferase-based reporters for NF-??B or p53 transcriptional activity. The knockout cells are also suited for viral replication assays to delineate the role of nuclear import in infection and for RNA-seq transcriptomic analyses to uncover downstream gene expression changes. These cells are an essential tool for drug discovery programs targeting nucleocytoplasmic transport and for fundamental cancer biology research. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)